Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(25 sites)

France

Institut de Cancerologie de L'Ouest (Ico), Angers

Hopital Jean Minjoz, Besançon

Institut Bergonie, Bordeaux

Centre Francois Baclesse, Caen

Centre Jean Perrin, Clermont-Ferrand